Intelligent Investor

Universal Biosensors, Inc. (ASX: UBI) - Announcements

- Current share price for UBI : $0.165

ASX company news and announcements for Universal Biosensors, Inc. (UBI) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Universal Biosensors, Inc. (UBI) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Universal Biosensors, Inc. (UBI), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Universal Biosensors, Inc. (UBI)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$38 Entitlement Offer Opens and Despatch of Prospectus 19 Apr 2024 9:00AM $0.165 $0.165 $0.180 fallen by 0%
$38 Update - Proposed issue of securities - UBI 11 Apr 2024 10:23AM $0.180 $0.165 $0.180 fallen by 8.33%
$38 Letter to Optionholders 11 Apr 2024 10:06AM $0.185 $0.165 $0.180 fallen by 10.81%
$38 Letter to Ineligible Securityholders 11 Apr 2024 10:02AM $0.185 $0.165 $0.180 fallen by 10.81%
$38 Letter to Eligible Securityholders 11 Apr 2024 10:01AM $0.185 $0.165 $0.180 fallen by 10.81%
$38 UBI - Target Market Determination 11 Apr 2024 9:57AM $0.185 $0.165 $0.180 fallen by 10.81%
$38 UBI Prospectus 11 Apr 2024 9:57AM $0.185 $0.165 $0.180 fallen by 10.81%
$38 Entitlement Offer Launch Announcement 11 Apr 2024 9:55AM $0.185 $0.165 $0.180 fallen by 10.81%
$38 Results of 2024 Special Meeting of Stockholders 10 Apr 2024 10:53AM $0.190 $0.165 $0.180 fallen by 13.16%
$38 Notice of Meeting/Proxy Statement 9 Apr 2024 9:15AM $0.195 $0.165 $0.180 fallen by 15.38%
$38 Change in substantial holding 26 Mar 2024 12:41PM $0.190 $0.165 $0.180 fallen by 13.16%
$38 Appendix 3Y - Craig Coleman 26 Mar 2024 12:27PM $0.190 $0.165 $0.180 fallen by 13.16%
$38 Becoming a substantial holder from HNG 26 Mar 2024 9:30AM $0.200 $0.165 $0.180 fallen by 17.50%
$38 Notice of Meeting of Stockholders on 10 April 2024 26 Mar 2024 9:02AM $0.200 $0.165 $0.180 fallen by 17.50%
$38 Application for quotation of securities - UBI 25 Mar 2024 2:07PM $0.205 $0.165 $0.180 fallen by 19.51%
$38 Application for quotation of securities - UBI 25 Mar 2024 9:52AM $0.210 $0.165 $0.180 fallen by 21.43%
$38 Change in substantial holding 25 Mar 2024 9:15AM $0.210 $0.165 $0.180 fallen by 21.43%
$38 Placement Cleansing Notice 25 Mar 2024 9:01AM $0.210 $0.165 $0.180 fallen by 21.43%
$38 Application for quotation of securities - UBI 25 Mar 2024 8:54AM $0.210 $0.165 $0.180 fallen by 21.43%
$38 Update - Proposed issue of securities - UBI 22 Mar 2024 9:57AM $0.220 $0.165 $0.180 fallen by 25%
$38 Update - Proposed issue of securities - UBI 22 Mar 2024 9:51AM $0.220 $0.165 $0.180 fallen by 25%
$38 Placement Results Announcement 22 Mar 2024 9:07AM $0.220 $0.165 $0.180 fallen by 25%
$38 FDA Approval for Xprecia Prime 19 Mar 2024 10:37AM $0.160 $0.165 $0.180 risen by 3.13%
$38 Trading Halt 18 Mar 2024 9:03AM $0.160 $0.165 $0.180 risen by 3.13%
$38 CEO to Exercise Options 5 Mar 2024 9:12AM $0.135 $0.165 $0.180 risen by 22.22%

1 - 25 of 567 results

Page 1 of 23

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.